BiO2 Medical

The current objective for BiO2 Medical is to investigate, manufacture, and commercialize the Angel® Catheter; to provide prophylactic Pulmonary Embolism protection and access to the central venous system in critically ill patients. Pictured here is Mrs. Doreen Carter, the first patient to receive BiO2 Medical’s Angel® Catheter in the European Union at Royal Berkshire Hospital, in Reading, UK. Dr. Carl Waldmann, Consultant Anaesthetist & Intensive Care, Royal Berkshire NHS Trust, was quoted on BBC Radio as saying, “the new device can have a dramatic impact on most patients in intensive care who cannot be given anti-blood clotting medications.”

With the innovative Angel® Catheter, BiO2 Medical is focused on providing prophylactic Pulmonary Embolism (PE) protection and access to the central venous system in critically ill patients worldwide.
For information on clinical studies of the Angel® Catheter visit ClinicalTrials.gov

BiO2 Medical’s Research and Development Team has over 30 years...Learn More >

Welcome to BiO2 Medical

BiO2 Medical, Inc. was founded in December of 2006, by Luis F. Angel, MD, Christopher E. Banas, and Paul Castella, PhD. The company was formed to design, develop, and subsequently manufacture a range of novel medical devices, in response to unmet clinical needs.

The current objective for BiO2 Medical is to investigate, manufacture, and commercialize the Angel® Catheter; an innovative medical device designed to provide prophylactic Pulmonary Embolism protection and access to the central venous system in critically ill patients.

BiO2 Medical has corporate headquarters in San Antonio, Texas, and a research and development (R&D) and manufacturing facility in Golden, Colorado. The Golden, Colorado facility is certified per ISO 13485:2003 and includes a state of the art 1,000 ft.2 clean room certified as a class 8 (100,000) controlled environment (CER).